Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Some Birth Control Pills Safer Than Others


Related Encyclopedia
 border=
AIDS and HIV Infection
Amenorrhea
Amniocentesis
Amniocentesis and CVS
More...

Related Healthscout Videos
 border=
How Do I Find a Good Bra Post-Mastectomy?
How Do I Deal with Hair Loss After Chemotherapy for Breast Cancer?
How Do I Talk to My Doctor About Medical Options After a Breast Cancer Diagnosis?
Exercises that Help Menopausal Symptoms
More...

Related Animations
 border=
Angioplasty
Breast Reduction
Breast Self-Exam Video
Coronary Bypass Surgery
More...

Related Drug Information
 border=
Accupril
Actonel
Altace
Avapro
More...

Related News Articles
 border=
Mom's Weight Before Pregnancy May Affect Weight of Child
Experts Support FDA Panel's Backing of New Blood Thinner
More Women to Get Health Insurance Under Affordable Care Act
Calcium Supplements Linked to Boost in Heart Attack Risk
More...


Page:  << Prev | 1 | 2

Pills with equal doses of estrogen that contained the progestogen desogestrel had double the risk of the pills using levonorgestrel, the researchers found.

The Danish study of all women aged 15 to 49 from 1995 to 2005 found roughly the same association.

In general, the newer oral contraceptives have a higher risk than the older ones, Lidegaard said. "The fourth-generation pills are not safer than the first-generation pills, which we had not expected," he said.

Text Continues Below



For women who want to use an oral contraceptive and are at higher risk because of obesity or a family history of venous thromboembolism, "it would be wise to take a second-generation product," Lidegaard said.

While the study looked at oral contraceptives marketed in Europe, the results apply to "all women in industrial countries," said Dr. Astrid van Hylckama Vlieg, a research fellow in the department of clinical epidemiology at Leiden University and a member of the Dutch research team.

"In the United States, you have several products we describe," she said.

It won't be easy for a woman to act on the information in the studies, she said. "By just looking at the package, you can't tell which generation of progestogen is used," she said. A consultation with the physician writing the prescription is advisable, she said.

"The message of these studies is that all the pills are effective as contraceptives if taken as directed, and that side effects have to do with the choice of pill," said Dr. Nick Dunn, a senior lecturer in medical education at the University of Southampton Medical School in England, who wrote an accompanying editorial.

While the risk of venous blood clots is very small, it cannot be disregarded, Dunn said. "Women with any sort of family history should think very carefully before taking any contraceptive pill," he said. "These papers strongly suggest that there are safer pills among the choices that are available."

More information

Learn about oral contraceptives from the U.S. National Library of Medicine.

Page:  << Prev | 1 | 2

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 8/14/2009

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCES: Ojvind Lidegaard, M.D., professor, obstetrics and gynecology, Rigshospitalet, Copenhagen, Denmark; Astrid van Hylckama Vlieg, M.D., research fellow, department of clinical epidemiology, Leiden University, Netherlands; Nick Dunn, M.D., senior lecturer, medical education, University of Southampton Medical School, England; Aug, 14, 2009, BMJ, online


About The HealthScout Network Contact Us
Copyright © 2001-2010. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy